M
Margery Gass
Researcher at North American Menopause Society
Publications - 30
Citations - 4202
Margery Gass is an academic researcher from North American Menopause Society. The author has contributed to research in topics: Women's Health Initiative & Menopause. The author has an hindex of 17, co-authored 30 publications receiving 3468 citations. Previous affiliations of Margery Gass include Cleveland Clinic Lerner College of Medicine & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.
Siobán D. Harlow,Margery Gass,Janet E. Hall,Roger A. Lobo,Pauline M. Maki,Robert W. Rebar,Sherry Sherman,Patrick M. Sluss,Tobie J. de Villiers +8 more
TL;DR: Application of the STRAW + 10 staging system should improve comparability of studies of midlife women and facilitate clinical decision making and provide a more comprehensive basis for assessing reproductive aging in research and clinical contexts.
Journal ArticleDOI
Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging.
Siobán D. Harlow,Margery Gass,Janet E. Hall,Roger A. Lobo,Pauline M. Maki,Robert W. Rebar,Sherry Sherman,Patrick M. Sluss,Tobie J. de Villiers +8 more
TL;DR: STRAW +10 provides a more comprehensive basis for assessing reproductive aging in research and clinical contexts and should improve comparability of studies of midlife women and facilitate clinical decision making.
Journal ArticleDOI
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.
David Portman,Margery Gass +1 more
TL;DR: The term genitourinary syndrome of menopause (GSM) is a medically more accurate, all-encompassing, and publicly acceptable term than vulvovaginal atrophy and was formally endorsed by the respective Boards of NAMS and ISSWSH in 2014.
Journal ArticleDOI
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women ' s Sexual Health and The North American Menopause Society
David Portman,Margery Gass +1 more
TL;DR: GSM is defined as a collection of symptoms and signs associated with a decrease in estrogen and other sex steroids involving changes to the labia majora/minora, clitoris, vestibule/introitus, vagina, urethra and bladder.
Journal ArticleDOI
Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.
Garnet L. Anderson,Rowan T. Chlebowski,Aaron K. Aragaki,Lewis H. Kuller,JoAnn E. Manson,Margery Gass,Elizabeth C. Bluhm,Stephanie Connelly,F. Allan Hubbell,Dorothy S. Lane,Lisa W. Martin,Judith K. Ockene,Thomas E. Rohan,Robert S. Schenken,Jean Wactawski-Wende +14 more
TL;DR: The findings provide reassurance for women with hysterectomy seeking relief of climacteric symptoms in terms of the effects of oestrogen use for about 5 years on breast cancer incidence and mortality, but the data do not support use of Oestrogen for breast cancer risk reduction.